Acknowledgement
This study was supported by the Intelligent Synthetic Biology Center of the Global Frontier Project, funded by the Ministry of Education, Science, and Technology (2013-0073185); and an MRC grant (2018R1A5A2020732) and National Research Foundation (NRF) of Korea grant (2019R1A2C2006475; 2019R1C1C1009705) funded by the Korean government (MSIT).
References
- Lee S, Lane AP. Chronic rhinosinusitis as a multifactorial inflammatory disorder. Current Infectious Disease Reports 2011;13(2):159-68. https://doi.org/10.1007/s11908-011-0166-z
- Schleimer RP. Immunopathogenesis of chronic rhinosinusitis and nasal polyposis. Annu Rev Pathol 2017;12(1):331-57. https://doi.org/10.1146/annurev-pathol-052016-100401
- Akdis CA, Bachert C, Cingi C, Dykewicz MS, Hellings PW, Naclerio RM, et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European academy of allergy and clinical immunology and the American academy of allergy, asthma & immunology. J Allergy Clin Immunol 2013;131(6):1479-90. https://doi.org/10.1016/j.jaci.2013.02.036
- Van Crombruggen K, Zhang N, Gevaert P, Tomassen P, Bachert C. Pathogenesis of chronic rhinosinusitis: inflammation. J Allergy Clin Immunol 2011;128(4):728-32. https://doi.org/10.1016/j.jaci.2011.07.049
- Kato A. Immunopathology of chronic rhinosinusitis. Allergology International 2015;64(2):121-30. https://doi.org/10.1016/j.alit.2014.12.006
- Lopez-Chacon M, Mullol J, Pujols L. Clinical and biological markers of difficult-to-treat severe chronic rhinosinusitis. Curr Allergy Asthma Rep 2015;15(5):19. https://doi.org/10.1007/s11882-015-0520-6
- Shah SA, Ishinaga H, Takeuchi K. Pathogenesis of eosinophilic chronic rhinosinusitis. Journal of Inflammation 2016;13:11. https://doi.org/10.1186/s12950-016-0121-8
- Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008;9(5):503-10. https://doi.org/10.1038/ni1582
- Long EO, Sik Kim H, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 2013;31:227-58. https://doi.org/10.1146/annurev-immunol-020711-075005
- Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002;195(3):343-51. https://doi.org/10.1084/jem.20011149
- Duvall MG, Barnig C, Cernadas M, Ricklefs I, Krishnamoorthy N, Grossman NL, et al. Natural killer cell-mediated inflammation resolution is disabled in severe asthma. Sci Immunol 2017;2(9):eaam5446. https://doi.org/10.1126/sciimmunol.aam5446
- Awad A, Yassine H, Barrier M, Vorng H, Marquillies P, Tsicopoulos A, et al. Natural killer cells induce eosinophil activation and apoptosis. PLoS One 2014;9(4):e94492. https://doi.org/10.1371/journal.pone.0094492
- Haworth O, Cernadas M, Levy BD. NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation. J Immunol 2011;186(11):6129-35. https://doi.org/10.4049/jimmunol.1004007
- Kim JH, Choi GE, Lee B-J, Kwon SW, Lee S-H, Kim HS, et al. Natural killer cells regulate eosinophilic inflammation in chronic rhinosinusitis. Scientific Reports 2016;6:27615. https://doi.org/10.1038/srep27615
- Kim JH, Kim GE, Cho GS, Kwon HJ, Joo CH, Kim HS, et al. Natural killer cells from patients with chronic rhinosinusitis have impaired effector functions. PLoS One 2013;8(10):e77177. https://doi.org/10.1371/journal.pone.0077177
- Ikeda K, Ito S, Hibiya R, Homma H, Ono N, Okada H, et al. Postoperative management of eosinophilic chronic rhinosinusitis with nasal polyps: impact of high-dose corticosteroid nasal spray. Int Arch Otorhinolaryngol 2019;23(1):101-3. https://doi.org/10.1055/s-0038-1668515
- Fujieda S, Imoto Y, Kato Y, Ninomiya T, Tokunaga T, Tsutsumiuchi T, et al. Eosinophilic chronic rhinosinusitis. Allergol Int 2019;68(4):403-12. https://doi.org/10.1016/j.alit.2019.07.002
- Stjarne P, Olsson P, Alenius M. Use of mometasone furoate to prevent polyp relapse after endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg 2009;135(3):296-302. https://doi.org/10.1001/archoto.2009.2
- Walsh LJ, Lewis SA, Wong CA, Cooper S, Oborne J, Cawte SA, et al. The impact of oral corticosteroid use on bone mineral density and vertebral fracture. Am J Respir Crit Care Med 2002;166(5):691-5. https://doi.org/10.1164/rccm.2110047
- Jung JH, Kang IG, Kim DY, Hwang YJ, Kim ST. The effect of Korean red ginseng on allergic inflammation in a murine model of allergic rhinitis. Journal of Ginseng Research 2013;37(2):167-75. https://doi.org/10.5142/jgr.2013.37.167
- Lee CH, Kim JH. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J Ginseng Res 2014;38(3):161-6. https://doi.org/10.1016/j.jgr.2014.03.001
- Kwon H-J, Lee H, Choi G-E, Kwon SJ, Song AY, Kim SJ, et al. Ginsenoside F1 promotes cytotoxic activity of NK cells via insulin-like growth factor-1-dependent mechanism. Frontiers in Immunology 2018;9:2785. https://doi.org/10.3389/fimmu.2018.02785
- Jia L, Zhao Y. Current evaluation of the millennium phytomedicine-ginseng (I): etymology, pharmacognosy, phytochemistry, market and regulations. Current Medicinal Chemistry 2009;16(19):2475-84. https://doi.org/10.2174/092986709788682146
- Kim JH, Yi YS, Kim MY, Cho JY. Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases. J Ginseng Res 2017;41(4):435-43. https://doi.org/10.1016/j.jgr.2016.08.004
- Leung KW, Wong AS-T. Pharmacology of ginsenosides: a literature review. Chinese Medicine 2010;5:20. https://doi.org/10.1186/1749-8546-5-20
- Quan K, Liu Q, Wan JY, Zhao YJ, Guo RZ, Alolga RN, et al. Rapid preparation of rare ginsenosides by acid transformation and their structure-activity relationships against cancer cells. Sci Rep 2015;5:8598. https://doi.org/10.1038/srep08598
- Chen RJ, Chung TY, Li FY, Lin NH, Tzen JT. Effect of sugar positions in ginsenosides and their inhibitory potency on Na+/K+-ATPase activity. Acta Pharmacologica Sinica 2009;30(1):61-9. https://doi.org/10.1038/aps.2008.6
- Im DS. Pro-resolving effect of ginsenosides as an anti-inflammatory mechanism of Panax ginseng. Biomolecules 2020;10(3):444. https://doi.org/10.3390/biom10030444
- Han MJ, Kim DH. Effects of red and fermented ginseng and ginsenosides on allergic disorders. Biomolecules 2020;10(4):634. https://doi.org/10.3390/biom10040634
- Li LC, Piao HM, Zheng MY, Lin ZH, Choi YH, Yan GH. Ginsenoside Rh2 attenuates allergic airway inflammation by modulating nuclear factor-kappaB activation in a murine model of asthma. Molecular Medicine Reports 2015;12(5):6946-54. https://doi.org/10.3892/mmr.2015.4272
- Lee IS, Uh I, Kim KS, Kim KH, Park J, Kim Y, et al. Anti-inflammatory effects of ginsenoside Rg3 via NF-kappaB pathway in A549 cells and human asthmatic lung tissue. Journal of Immunology Research 2016;2016:7521601. https://doi.org/10.1155/2016/7521601
- Kim HI, Kim JK, Kim JY, Han MJ, Kim DH. Fermented red ginseng and ginsenoside Rd alleviate ovalbumin-induced allergic rhinitis in mice by suppressing IgE, interleukin-4, and interleukin-5 expression. Journal of Ginseng Research 2019;43(4):635-44. https://doi.org/10.1016/j.jgr.2019.02.006
- Oh HA, Seo JY, Jeong HJ, Kim HM. Ginsenoside Rg1 inhibits the TSLP production in allergic rhinitis mice. Immunopharmacol Immunotoxicol 2013;35(6):678-86. https://doi.org/10.3109/08923973.2013.837061
- Kim JK, Cui CH, Yoon MH, Kim SC, Im WT. Bioconversion of major ginsenosides Rg1 to minor ginsenoside F1 using novel recombinant ginsenoside hydrolyzing glycosidase cloned from Sanguibacter keddieii and enzyme characterization. Journal of Biotechnology 2012;161(3):294-301. https://doi.org/10.1016/j.jbiotec.2012.06.021
- Choi GE, Yoon SY, Kim JY, Kang DY, Jang YJ, Kim HS. Autophagy deficiency in myeloid cells exacerbates eosinophilic inflammation in chronic rhinosinusitis. J Allergy Clin Immunol 2018;141(3):938-950 e12. https://doi.org/10.1016/j.jaci.2017.10.038
- Khalmuratova R, Lee M, Park JW, Shin HW. Evaluation of neo-osteogenesis in eosinophilic chronic rhinosinusitis using a nasal polyp murine model. Allergy Asthma Immunol Res 2020;12(2):306-21. https://doi.org/10.4168/aair.2020.12.2.306
- Zappia CD, Soto A, Granja-Galeano G, Fenoy I, Fernandez N, Davio CA, et al. Azelastine potentiates antiasthmatic dexamethasone effect on a murine asthma model. Pharmacol Res Perspect 2019;7(6):e00531.
- Lindsay R, Slaughter T, Britton-Webb J, Mog SR, Conran R, Tadros M, et al. Development of a murine model of chronic rhinosinusitis. Otolaryngol Head Neck Surg 2006;134(5):724-30. discussion 31-2. https://doi.org/10.1016/j.otohns.2005.11.048
- Qi LW, Wang CZ, Yuan CS. American ginseng: potential structure-function relationship in cancer chemoprevention. Biochem Pharmacol 2010;80(7):947-54. https://doi.org/10.1016/j.bcp.2010.06.023
- Pawankar R, Lee KH, Nonaka M, Takizawa R. Role of mast cells and basophils in chronic rhinosinusitis. Clin Allergy Immunol 2007;20:93-101.
- Di Lorenzo G, Drago A, Esposito Pellitteri M, Candore G, Colombo A, Gervasi F, et al. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis. Int Arch Allergy Immunol 2001;125(2):164-75. https://doi.org/10.1159/000053811
- Okano M, Fujiwara T, Yamamoto M, Sugata Y, Matsumoto R, Fukushima K, et al. Role of prostaglandin D2 and E2 terminal synthases in chronic rhinosinusitis. Clin Exp Allergy 2006;36(8):1028-38. https://doi.org/10.1111/j.1365-2222.2006.02528.x
- Kumar D, Hosse J, von Toerne C, Noessner E, Nelson PJ. JNK MAPK pathway regulates constitutive transcription of CCL5 by human NK cells through SP1. J Immunol 2009;182(2):1011-20. https://doi.org/10.4049/jimmunol.182.2.1011
- Fauriat C, Long EO, Ljunggren HG, Bryceson YT. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 2010;115(11):2167-76. https://doi.org/10.1182/blood-2009-08-238469
- Ashraf M, Murakami M, Kudo I. Cross-linking of the high-affinity IgE receptor induces the expression of cyclo-oxygenase 2 and attendant prostaglandin generation requiring interleukin 10 and interleukin 1 beta in mouse cultured mast cells. Biochem J 1996;320(Pt 3):965-73. https://doi.org/10.1042/bj3200965
- Hultner L, Kolsch S, Stassen M, Kaspers U, Kremer JP, Mailhammer R, et al. In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9. J Immunol 2000;164(11):5556-63. https://doi.org/10.4049/jimmunol.164.11.5556
- Castro F, Cardoso AP, Goncalves RM, Serre K, Oliveira MJ. Interferon-gamma at the crossroads of tumor immune surveillance or evasion. Frontiers in Immunology 2018;9:847. https://doi.org/10.3389/fimmu.2018.00847
- Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58(11):1685-93. https://doi.org/10.1016/S0006-2952(99)00212-9
- Ramaswami R, Stebbing J. Ginseng: panacea among herbal remedies? The Lancet Oncology 2013;14(3):195-6. https://doi.org/10.1016/S1470-2045(13)70081-0
- Liu CX, Xiao PG. Recent advances on ginseng research in China. J Ethnopharmacol 1992;36(1):27-38. https://doi.org/10.1016/0378-8741(92)90057-X
- Zhang N, Van Zele T, Perez-Novo C, Van Bruaene N, Holtappels G, DeRuyck N, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 2008;122(5):961-8. https://doi.org/10.1016/j.jaci.2008.07.008
- Van Zele T, Holtappels G, Gevaert P, Bachert C. Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy 2014;28(3):192-8. https://doi.org/10.2500/ajra.2014.28.4033
- Kolbeck R, Kozhich A, Koike M, Peng L, Andersson CK, Damschroder MM, et al. MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function. J Allergy Clin Immunol 2010;125(6):1344-13453 e2. https://doi.org/10.1016/j.jaci.2010.04.004
- Wechsler ME, Fulkerson PC, Bochner BS, Gauvreau GM, Gleich GJ, Henkel T, et al. Novel targeted therapies for eosinophilic disorders. J Allergy Clin Immunol 2012;130(3):563-71. https://doi.org/10.1016/j.jaci.2012.07.027
- Haworth O, Cernadas M, Levy BD. NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation. J Immunol 2011;186(11):6129-35. https://doi.org/10.4049/jimmunol.1004007
- Jung JH, Kang TK, Oh JH, Jeong JU, Ko KP, Kim ST. The effect of Korean red ginseng on symptoms and inflammation in patients with allergic rhinitis. Ear Nose Throat J 2020. 145561320907172:online ahead of print.
- Du J, Cheng B, Zhu X, Ling C. Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects. J Immunol 2011;187(2):942-50. https://doi.org/10.4049/jimmunol.1002579
- Jyonouchi H, Sun S, Le H, Rimell FL. Evidence of dysregulated cytokine production by sinus lavage and peripheral blood mononuclear cells in patients with treatment-resistant chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2001;127(12):1488-94. https://doi.org/10.1001/archotol.127.12.1488
- Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab Disposit 2003;31:1065-71. https://doi.org/10.1124/dmd.31.8.1065